{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:48:19Z","timestamp":1786718899508,"version":"build-2736575974"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Community Med"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jfcm.jfcm_74_18","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T04:48:04Z","timestamp":1549860484000},"page":"61","source":"Crossref","is-referenced-by-count":2,"title":["Chest pain as a possible side effect of pitavastatin (Livalo)"],"prefix":"10.4103","volume":"26","author":[{"given":"NadaR","family":"AlZahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmnaF","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8229.249393-1","first-page":"921","volume-title":"Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals","author":"Saito","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/2230-8229.249393-2","first-page":"709","volume-title":"A large-scale, long-term, prospective post-marketing surveillance of pitavastatin","author":"Kurihara","year":"2008","journal-title":"Jpn Pharmacol Ther"},{"key":"key-10.4103\/2230-8229.249393-3","first-page":"404","volume-title":"The effect of intensified low density lipoprotein cholesterol reduction on recurrent myocardial infarction and cardiovascular mortality","author":"Huang","year":"2013","journal-title":"Acta Cardiol Sin"},{"key":"key-10.4103\/2230-8229.249393-4","unstructured":"LIVALO\u00ae (Pitavastatin) Tablets | Safety Information; 2018. Available from: https:\/\/www.livalohcp.com\/statin-medication\/pitavastatin-safety-information. [Last accessed on 2018 Jul 17]."},{"key":"key-10.4103\/2230-8229.249393-5","first-page":"16","volume-title":"Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients","author":"Manderbacka","year":"2008","journal-title":"Int J Equity Health"},{"key":"key-10.4103\/2230-8229.249393-6","first-page":"82","volume-title":"Risk identification and possible countermeasures for muscle adverse effects during statin therapy","author":"Magni","year":"2015","journal-title":"Eur J Intern Med"}],"container-title":["Journal of Family and Community Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:41:09Z","timestamp":1786714869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfcm.JFCM_74_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["249393"],"URL":"https:\/\/doi.org\/10.4103\/jfcm.jfcm_74_18","relation":{},"ISSN":["2230-8229"],"issn-type":[{"value":"2230-8229","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}